What's Going On With Cassava Sciences Today?
Portfolio Pulse from Vaishali Prayag
Cassava Sciences, Inc. (NASDAQ:SAVA) shares are trading higher due to an upcoming conference call, extended trials for simufilam, and the passing of a long-time board member. Analysts expect an EPS loss of 40 cents.
August 05, 2024 | 7:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cassava Sciences shares are up 20.9% due to an upcoming conference call, extended simufilam trials, and the passing of a board member. Analysts expect an EPS loss of 40 cents.
The stock price increase is driven by positive sentiment around the upcoming conference call and the extension of simufilam trials. The expected EPS loss is already factored in by the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100